Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Lehmann

Showing results (61-70 of 209) with videos related to

Pageof 21
Sort By:
Clinical Chemistry|November 11, 2006
Quantitative high-resolution CpG island mapping with Pyrosequencing reveals disease-specific methylation patterns of the CDKN2B gene in myelodysplastic syndrome and myeloid leukemiaKai Brakensiek, Luzie U Wingen, Florian Länger, et al.
Hepatology (Baltimore, Md.)|January 12, 2002
High frequency of epithelial chimerism in liver transplants demonstrated by microdissection and STR-analysisWolfram Kleeberger, Thomas Rothämel, Sabine Glöckner, et al.
Cancer Letters|November 29, 2011
ABCB1/MDR1 contributes to the anticancer drug-resistant phenotype of IPH-926 human lobular breast cancer cellsTill Krech, Elisa Scheuerer, Robert Geffers, et al.
The American Journal of Pathology|February 13, 2002
Quantitative assessment of promoter hypermethylation during breast cancer developmentUlrich Lehmann, Florian Länger, Henning Feist, et al.
Haematologica|September 6, 2013
Archival bone marrow trephines are suitable for high-throughput mutation analysis using next generation sequencing technologyBritta Hasemeier, Robert Geffers, Stephan Bartels, et al.
Plos One|September 12, 2013
Is upregulation of BCL2 a determinant of tumor development driven by inactivation of CDH1/E-cadherin?Inga Karch, Elisa Schipper, Henriette Christgen, et al.
Genes, Chromosomes & Cancer|September 6, 2023
Frequency of genetic alterations differs in advanced breast cancer between metastatic sitesIsabel Grote, Alexandra Poppe, Ulrich Lehmann, et al.
Clinical Epigenetics|February 5, 2021
Genome-wide DNA methylation profiling is able to identify prefibrotic PMF cases at risk for progression to myelofibrosisUlrich Lehmann, Helge Stark, Stephan Bartels, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 16, 2011
Optimized RNA extraction from non-deparaffinized, laser-microdissected materialDanny Jonigk, Friedrich Modde, Clemens L Bockmeyer, et al.
Disease Markers|June 12, 2012
Limited value of KAI1/CD82 protein expression as a prognostic marker in human gastric cancerMaximilian Knoener, Till Krech, Florian Puls, et al.
Pageof 21

Showing results (61-70 of 209) with videos related to

Sort By:
Pageof 21
Clinical Chemistry|November 11, 2006
Quantitative high-resolution CpG island mapping with Pyrosequencing reveals disease-specific methylation patterns of the CDKN2B gene in myelodysplastic syndrome and myeloid leukemiaKai Brakensiek, Luzie U Wingen, Florian Länger, et al.
Hepatology (Baltimore, Md.)|January 12, 2002
High frequency of epithelial chimerism in liver transplants demonstrated by microdissection and STR-analysisWolfram Kleeberger, Thomas Rothämel, Sabine Glöckner, et al.
Cancer Letters|November 29, 2011
ABCB1/MDR1 contributes to the anticancer drug-resistant phenotype of IPH-926 human lobular breast cancer cellsTill Krech, Elisa Scheuerer, Robert Geffers, et al.
The American Journal of Pathology|February 13, 2002
Quantitative assessment of promoter hypermethylation during breast cancer developmentUlrich Lehmann, Florian Länger, Henning Feist, et al.
Haematologica|September 6, 2013
Archival bone marrow trephines are suitable for high-throughput mutation analysis using next generation sequencing technologyBritta Hasemeier, Robert Geffers, Stephan Bartels, et al.
Plos One|September 12, 2013
Is upregulation of BCL2 a determinant of tumor development driven by inactivation of CDH1/E-cadherin?Inga Karch, Elisa Schipper, Henriette Christgen, et al.
Genes, Chromosomes & Cancer|September 6, 2023
Frequency of genetic alterations differs in advanced breast cancer between metastatic sitesIsabel Grote, Alexandra Poppe, Ulrich Lehmann, et al.
Clinical Epigenetics|February 5, 2021
Genome-wide DNA methylation profiling is able to identify prefibrotic PMF cases at risk for progression to myelofibrosisUlrich Lehmann, Helge Stark, Stephan Bartels, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 16, 2011
Optimized RNA extraction from non-deparaffinized, laser-microdissected materialDanny Jonigk, Friedrich Modde, Clemens L Bockmeyer, et al.
Disease Markers|June 12, 2012
Limited value of KAI1/CD82 protein expression as a prognostic marker in human gastric cancerMaximilian Knoener, Till Krech, Florian Puls, et al.
Pageof 21